BlackRock »

Acumen Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.1M 2.4M 1.72
2024-09-30 $5.8M 2.3M 2.48

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
BlackRock
FMR
Vanguard Group
Rock Springs Capital Management
Knollwood Investment Advisory
Millennium Management
Alyeska Investment Group
Jpmorgan Chase & Co
Geode Capital Management
Laurion Capital Management
Hudson Bay Capital Management
Pathstone Holdings

View all funds holding Acumen Pharmaceuticals